Of note, MHC class II+ macrophages and microglia were not distinguished from each other in our in vivo studies; as both populations are important in MS pathogenesis, further studies could delineate the effects of caspase-3 and GSDMD activation in individual brain macrophage populations. This evidence concerns the gene CASP3 and myeloid sarcoma.